PITTSBURGH- Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Didier Barret to the position of President- EMEA (Europe- Middle East and Africa) following the completion of Mylan's acquisition of Merck's Generics Group today.
At Merck Generics- M. Barret most recently served as RegionDirector- EMEA- reporting to the CEO. He was promoted to thatposition in 2004 following his role as Area Director for SouthernEurope- where he was responsible for France- Belgium- Italy- Spainand Portugal. He established Merck Generics' first operations inFrance in 1995- growing the business to exceed euro 341 million insales by 2006. Prior to this- M. Barret held several positionswithin Merck's branded division- including sales and marketing inthe UK and France.

Seotud lood

  • ST
Sisuturundus
  • 22.04.26, 11:45
Saaremaa investeerib 100 000 eurot tervishoiutöötajate toetuseks
Tervishoiutöötajatest on Eestis suur nappus, seda eriti suurtest keskustest väljaspool. Saaremaa vald, kohalikud ettevõtjad ning Kuressaare Haigla on leidnud ja rakendanud aga mitut erinevat meedet, kuidas üheskoos seda olukorda parandada ja arste saarele tööle saada.

Hetkel kuum

Liitu uudiskirjaga

Telli uudiskiri ning saad oma postkasti päeva olulisemad uudised.

Tagasi Meditsiiniuudised esilehele